NOVO.B.DK

259.7

+2.85%↑

GMAB.DK

1,816.5

-2.05%↓

HLUNB.DK

41.76

+0.34%↑

ZEAL.DK

313.9

+3.43%↑

AMBUB.DK

68.15

+0.52%↑

NOVO.B.DK

259.7

+2.85%↑

GMAB.DK

1,816.5

-2.05%↓

HLUNB.DK

41.76

+0.34%↑

ZEAL.DK

313.9

+3.43%↑

AMBUB.DK

68.15

+0.52%↑

NOVO.B.DK

259.7

+2.85%↑

GMAB.DK

1,816.5

-2.05%↓

HLUNB.DK

41.76

+0.34%↑

ZEAL.DK

313.9

+3.43%↑

AMBUB.DK

68.15

+0.52%↑

NOVO.B.DK

259.7

+2.85%↑

GMAB.DK

1,816.5

-2.05%↓

HLUNB.DK

41.76

+0.34%↑

ZEAL.DK

313.9

+3.43%↑

AMBUB.DK

68.15

+0.52%↑

NOVO.B.DK

259.7

+2.85%↑

GMAB.DK

1,816.5

-2.05%↓

HLUNB.DK

41.76

+0.34%↑

ZEAL.DK

313.9

+3.43%↑

AMBUB.DK

68.15

+0.52%↑

Search

Coloplast A-S (Class B)

Atidarymo kaina

434.8 -0.32

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

430.1

Max

437.1

Pagrindiniai rodikliai

By Trading Economics

Pajamos

522M

1.4B

Pardavimai

83M

7B

P/E

Sektoriaus vid.

24.148

63.808

Pelnas, tenkantis vienai akcijai

6.32

Dividendų pajamingumas

5.41

Pelno marža

19.835

Darbuotojai

16,983

EBITDA

309M

2.3B

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+11.86% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

5.41%

2.38%

Kitas uždarbis

2026-05-12

Kitas dividendų mokėjimo data

2026-05-20

Kita Ex Dividend data

2026-05-18

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-22B

96B

Ankstesnė atidarymo kaina

435.12

Ankstesnė uždarymo kaina

434.8

Coloplast A-S (Class B) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-15 23:14; UTC

Uždarbis

Battery Maker CATL First-Quarter Net Rose on Strong Demand

2026-04-15 23:14; UTC

Uždarbis

Battery Maker CATL First Quarter Net Rose On Strong Demand

2026-04-15 17:13; UTC

Pagrindinės rinkos jėgos

Tesla Shares Rise on Completion of AI5 Chip Design Process

2026-04-15 23:39; UTC

Rinkos pokalbiai

Nikkei May Rise After Gains on Wall Street -- Market Talk

2026-04-15 23:35; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Rises Amid Hopes for More U.S.-Iran Talks -- Market Talk

2026-04-15 22:41; UTC

Uždarbis

CATL 1Q Net CNY20.74 Vs. Net CNY13.96B >300750.SZ

2026-04-15 22:38; UTC

Uždarbis

CATL 1Q Rev CNY129.13B Vs. CNY84.70B >300750.SZ

2026-04-15 22:15; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-04-15 22:15; UTC

Rinkos pokalbiai

J.B. Hunt Flag Fundamental Shift in 1Q -- Market Talk

2026-04-15 22:14; UTC

Uždarbis

Lens Technology Results Weighed by Lower Rev From Smartphone, Computer Business >300433.SZ

2026-04-15 22:12; UTC

Uždarbis

Lens Technology 1Q Oper Income CNY14.14B Vs. CNY17.06B>300433.SZ

2026-04-15 22:11; UTC

Uždarbis

Lens Technology 1Q Loss CNY149.60M Vs. Net CNY428.88M >300433.SZ

2026-04-15 22:11; UTC

Uždarbis

Lens Technology Swings to Loss in 1Q>300433.SZ

2026-04-15 22:07; UTC

Uždarbis

Big Bank Earnings Show Consumers Are on Solid Ground -- Against All Odds -- Barrons.com

2026-04-15 21:34; UTC

Įsigijimai, susijungimai, perėmimai

Skild AI Acquires Zebra Technologies' Robotics Automation Business

2026-04-15 21:29; UTC

Karštos akcijos

Stocks to Watch: Bank of America, Live Nation, Snap, Hermès -- WSJ

2026-04-15 20:50; UTC

Rinkos pokalbiai
Uždarbis

Financial Services Roundup: Market Talk

2026-04-15 20:30; UTC

Uždarbis

PepsiCo Cuts Prices, Revamps Products. Earnings Will Show if It's Working. -- Barrons.com

2026-04-15 20:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2026-04-15 20:06; UTC

Rinkos pokalbiai

Silver Inches Up as Attention Turns to World Deficit -- Market Talk

2026-04-15 19:46; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

Jamie Dimon Says JPMorgan Stock Isn't Cheap. Why the Bank Is Still Buying Back Billions. -- Barrons.com

2026-04-15 19:25; UTC

Rinkos pokalbiai

Automakers' 1Q Earnings Could Give Clues to EV Comeback -- Market Talk

2026-04-15 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Edges Up Ahead of Storage Data -- Market Talk

2026-04-15 18:58; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Settles Flat As Market Awaits Conflict Developments -- Market Talk

2026-04-15 18:11; UTC

Įsigijimai, susijungimai, perėmimai

Three Lessons From Amazon's Blockbuster Deal to Buy Globalstar -- Barrons.com

2026-04-15 17:45; UTC

Įsigijimai, susijungimai, perėmimai

Apple CEO Tim Cook Buys Nike Stock. His Last Purchase Didn't Go So Well. -- Barrons.com

2026-04-15 16:58; UTC

Uždarbis

Bank of America's Wealth Management Profits Rise Amid 'Resilient' U.S. Economy -- Barrons.com

2026-04-15 16:52; UTC

Uždarbis

Snap and Other Companies Blame AI for Layoffs. Is It Just a Convenient Excuse? -- Barrons.com

2026-04-15 16:46; UTC

Rinkos pokalbiai
Svarbiausios naujienos

U.S. Crude Oil Stocks Finally See Drawdowns -- Market Talk

2026-04-15 16:37; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Coloplast A-S (Class B) Prognozė

Kainos tikslas

By TipRanks

11.86% į viršų

12 mėnesių prognozė

Vidutinis 901.38 DKK  11.86%

Aukščiausias 1,056 DKK

Žemiausias 720 DKK

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Coloplast A-S (Class B) kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

8 ratings

2

Pirkti

4

Laikyti

2

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat